Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in European older adults by high risk conditions type: results of SpIDnet/I-MOVE+ multicentre study

Camelia Savulescu, R. Carragher, A. SpIDnet/I-MOVE+ group

Research output: Contribution to conferenceAbstractpeer-review

Fingerprint

Dive into the research topics of 'Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in European older adults by high risk conditions type: results of SpIDnet/I-MOVE+ multicentre study'. Together they form a unique fingerprint.